Ultrasound eye stimulation study for vision restoration
Part of Eyes & vision, Genetic & congenital clinical trials.
This study tests a non-invasive (no surgery) ultrasound stimulation approach to see if it can help restore vision in people with age-related macular degeneration (AMD) or retinitis pigmentosa (RP). It focuses on whether the treatment can be safely given and whether vision-related changes can be measured.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have AMD (any stage/type) or retinitis pigmentosa (RP)
- You are 18 years old or older
- You do not have other eye conditions besides AMD or RP
- You have no allergy history to ultrasound gel used during the scans
- You can follow the study instructions and attend all testing visits
- You can keep your eye steady enough to get clear pictures during testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a quick, noninvasive eye test that measures how well you see in the dark, which can be an early sign of dry AMD. Researchers want to see if the test relates to everyday tasks like reading or driving at night.
This trial tests a new type of electrical stimulation, called microcurrent therapy, to see if it can help people with a certain form of age-related macular degeneration (AMD) that is not the "wet" kind. The treatment is delivered through an eye patch-like device and may slow vision loss or improve function.
This trial studies whether a new, very high-resolution and high-speed eye scan can be used for people with eye problems or for healthy volunteers. It may help doctors better “see” eye structures more clearly to guide care.
This study uses a special, high-resolution camera to take detailed pictures of the back of the eye. It is testing the camera's ability to see changes in the retina for people who are healthy or have age-related macular degeneration, diabetic retinopathy, or other conditions that affect autofluorescence patterns.
This research study tests a new camera technology that takes detailed pictures of the back of your eye (retina) to better understand eye diseases. Researchers want to compare images from people with eye conditions like diabetes-related eye disease, glaucoma, or age-related macular degeneration with healthy volunteers to see how the new imaging works.
This trial tests a new treatment called Eyecyte-RPE™, made from special cells that support the retina. It is given as a single injection under the retina during eye surgery. The study aims to see if it can help people with advanced dry age-related macular degeneration (AMD) who have large areas of damage (geographic atrophy) in the center of their vision.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.